Koers Cannabics Pharmaceuticals Inc. Other OTC
Aandelen
CNBX
US13764M1009
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | 410K 381K | Marktkapitalisatie | 353K 328K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,79 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,79 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,64 mln. 1,53 mln. | Nettoschuld 2023 | 1,21 mln. 1,13 mln. | EV/omzet 2023 | 3,82 x |
K/w-verhouding 2022 |
-1,12
x | K/w-verhouding 2023 |
-0,04
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15-09-04 |
Gabriel Yariv
CHM | Chairman | 47 | 07-10-19 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 05-11-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15-09-04 |
Gabriel Yariv
CHM | Chairman | 47 | 07-10-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,44% | 122 mld. | |
+18,94% | 113 mld. | |
+18,72% | 26,22 mld. | |
-25,37% | 19,01 mld. | |
-19,79% | 15,71 mld. | |
-20,20% | 15,22 mld. | |
-47,37% | 14,72 mld. | |
+59,91% | 14,58 mld. | |
+4,35% | 13,84 mld. |